NCT05161195 2026-02-02
Roll-over Study to Allow Continued Access to Ribociclib
Novartis
Phase 4 Active not recruiting
Clinical Trials
7 trialsNCT05631795 2025-12-03
ALPINIST
Novartis
Phase 4 Completed
NCT05362760 2025-05-16
MINERVA
University of Ulm
Phase 4 Recruiting
NCT03220178 2022-01-06
PRECYCLE
Palleos Healthcare GmbH
Phase 4 Terminated
NCT02447328 2021-09-05
A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
AstraZeneca
Phase 4 Completed
NCT04031885 2021-08-24
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
Eli Lilly and Company
Phase 4 Terminated
NCT03591549 2018-07-23
Fulvestrant in Metastatic Breast Cancer
Assiut University
Phase 4 Unknown